Home > Clinical Trials
Check All Search

Saved trials

Completed
NCT02581280
Population Pharmacokinetics of Teicoplanin, Levofloxacin, Piperacillin/Tazobactam, Meropenem, Vancomycin, Remifentanil, Cefepime, Cefpirome, Sufentanil, Midazolam, Clopidogrel, Ticagrelor, Prasugrel During Veno-arterial Extracorporeal Membrane Oxygenation (VA ECMO)
56 Enrollment(s)
1 Study location(s)
Observational
Cardiac Dysfunction
Unknown status
NCT04146168
Lake Washington Vascular VenaSeal™ Post-Market Evaluation
124 Enrollment(s)
3 Study location(s)
Observational
Varicose Veins
Venous Reflux
Completed
NCT01560780
Prasugrel for Prevention of Early Saphenous Vein Graft Thrombosis
84 Enrollment(s)
4 Study location(s)
Interventional (Phase III)
Coronary Artery Bypass
Recruiting
NCT04010955
Adding Antiplatelet During Edoxaban Treatment in Stroke Patients With Non-valvular Atrial Fibrillation (ADD-ON)
1,200 Enrollment(s)
1 Study location(s)
Observational
Acute Ischemic Stroke
Atrial Fibrillation
Extracranial Atherosclerosis
Intracranial Atherosclerosis
Coronary Artery Atherosclerosis
Peripheral Artery Stenosis
Anticoagulant
Antiplatelet
Completed
NCT04006184
Retrospective Review of Saphenous Vein Incompetence: Venaseal Versus Endovenous Thermal Ablation
547 Enrollment(s)
1 Study location(s)
Observational
Varicose Veins
Venous Reflux
Venous Insufficiency
Terminated
NCT01794000
A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease (SCD)
341 Enrollment(s)
50 Study location(s)
Interventional (Phase III)
Sickle Cell Disease
Completed
NCT02942576
Edoxaban Treatment Versus Vitamin K Antagonist (VKA) in Patients With Atrial Fibrillation (AF) Undergoing Catheter Ablation
632 Enrollment(s)
75 Study location(s)
Interventional (Phase III)
Atrial Fibrillation
Completed
NCT01597375
Therapeutic Control of Aspirin-Exacerbated Respiratory Disease (Aspirin)
46 Enrollment(s)
1 Study location(s)
Interventional (Phase II)
Asthma, Aspirin-Induced
Aspirin Exacerbated Asthma